The pharma major beat analysts’ expectations in the fourth quarter of 2024, despite looming competition for its top heart drug Entresto.
Due in showrooms this February, the rebranded Cannon – formerly the Ute – is priced from $40,490 drive-away in Lux guise, a ...
Copart's impressive financials include a 45% gross profit margin. Read why CPRT stock is a Sell despite strong market ...
The funds will be strategically used to diversify Sammmm's product portfolio, amplify brand visibility, and establish a ...
Novartis expects profit and sales to grow further this year after beating analysts' expectations in the fourth quarter, boosted by revenue from its key drugs.
We recently compiled a list of the 10 Best Coal Stocks to Invest in Right Now. In this article, we are going to take a look ...
Active managers sometimes tout their ability to select stocks in markets that are considered less informationally efficient ...
On Wednesday, the city of Washington DC was the scene of a terrible air accident caused by a collision in mid-air between two ...
The CEO of a South Carolina primate research facility has blunt words for one of the animal rights organizations calling for the facility to be shut down.
The CEO of a Lowcountry primate research facility has blunt words for one of the animal rights organizations calling for the ...
A drunken man slipped on ice and fell in the parking lot of the Highlander Tavern Jan. 23. He refused medical treatment and ...
The news sent risk assets lower, with stocks giving up a chunk of earlier gains and bitcoin slipping back to $104,800.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback